Osteoporotic Vertebral Compression Fractures: What the Medical Literature Reports on Diagnosis and Treatment
An educational overview of what peer-reviewed reviews, randomized trials, systematic reviews, professional-society guidance, and current clinical practice report about vertebral compression fractures.
Osteoporotic vertebral compression fractures are fragility fractures of one or more vertebral bodies in the setting of reduced bone strength. They may be painful or discovered incidentally, and their imaging appearance ranges from mild vertebral wedging to substantial collapse. This article summarizes what peer-reviewed reviews, randomized trials, systematic reviews, professional-society guidance, and current clinical practice report about fracture characterization, natural history, treatment, and outcomes. It is intended as an educational overview.
How vertebral compression fractures are described
The term vertebral compression fracture describes a change in vertebral-body shape or height; it does not, by itself, establish when the change occurred or whether it is the source of current pain. Osteoporotic fragility fractures commonly involve the thoracic or lumbar spine, particularly around the thoracolumbar junction. Published clinical reviews distinguish these fractures from vertebral collapse associated with malignancy, infection, or higher-energy injury because those conditions have different causes and evidence bases.
Clinical studies define acute, subacute, and chronic fractures differently, using symptom timing, imaging findings such as marrow edema, or both. These differences affect study enrollment and comparison. A deformity may be old and asymptomatic, while a recent fracture can occur alongside preexisting vertebral changes.
Clinical presentation and imaging
Reviews commonly describe localized midline back pain after a low-energy event or without a clearly recalled injury. Pain may worsen with movement or loading, but some fractures produce few symptoms. Neurologic findings are not typical of uncomplicated compression fractures and may reflect posterior-wall involvement, canal compromise, or another condition.
Radiographs and CT show vertebral height loss and bony morphology but may not establish the age of a deformity. MRI can demonstrate marrow edema used to distinguish a recent or unhealed fracture from an older one. The North American Spine Society guideline describes edema localized to the painful level as evidence used to define an acute fracture when symptom onset is unclear. Imaging findings are interpreted with the reported time course, not as a standalone measure of pain.
Across imaging reviews and professional-society guidance, recurring points include:
- Radiographs and CT describe vertebral shape, height loss, and fracture morphology.
- MRI marrow edema is commonly used to identify a recent or incompletely healed fracture.
- Multiple vertebral deformities may have different ages, and a visible deformity may be asymptomatic.
- Imaging features, pain location, and symptom timing are related but distinct elements of the published diagnostic framework.
Natural history and nonprocedural care
Natural-history reviews and guideline summaries report that pain often improves over time, although the pace and extent vary. The NASS guideline, based on literature available through September 2020, describes significant improvement with medical treatment over several months to a year, while noting that some patients report persistent pain. Studies measure functional recovery and activity inconsistently.
Nonprocedural studies evaluate pain management, bracing, activity, and treatment of underlying osteoporosis. Evidence does not establish one regimen or brace type across all populations, and care duration varies between studies. Fracture-related pain and the broader management of bone fragility remain related but distinct areas of research.
Because pain may improve during fracture healing, observational studies cannot always separate treatment effects from the natural course without a suitable comparison group. This is one reason randomized studies and longer follow-up contribute differently to the evidence base.
Guideline syntheses describe pain improvement over periods of several months, while noting that persistent symptoms and functional limitations are also reported. Studies of bracing and activity differ in design and follow-up, and they do not establish a uniform recovery timetable. These findings describe population-level patterns rather than a predictable course for every fracture.
Osteoporosis guidance treats a vertebral fragility fracture as a marker of future fracture risk. A clinician's guide reports that vertebral fracture is associated with about a fivefold higher risk of another vertebral fracture and a two- to threefold higher risk of fracture at other sites. Secondary-fracture prevention literature addresses bone-health assessment separately from procedures intended to stabilize a painful vertebral body.
Vertebral augmentation procedures
Vertebroplasty and balloon kyphoplasty introduce polymethylmethacrylate cement into a fractured vertebral body under imaging guidance. Kyphoplasty adds balloon inflation before cement placement, creating a cavity and sometimes restoring part of the lost height. Studies evaluate both procedures for pain and function; radiographic restoration is a separate outcome and does not itself demonstrate symptom change. NASS guidance describes the procedures as having similar reported pain and function outcomes, while the degree of height restoration does not consistently correspond to greater symptomatic improvement.
Comparative trials use sham procedures, usual or nonsurgical care, and other augmentation procedures as controls. Sham-controlled studies account for procedural context and expectation effects, while unblinded comparisons measure a procedure alongside its care pathway. These controls do not represent the same treatment contrast.
Comparative outcomes and differing evidence
Systematic reviews and meta-analyses do not report one uniform conclusion about vertebroplasty. A Cochrane review of 21 trials, including five sham-controlled trials, found that the average one-month pain difference from sham was 0.6 points on a 0–10 scale, below the review's threshold for clinical importance. Its primary comparison did not support routine use for acute or subacute osteoporotic fractures. Comparisons with usual care produced more variable estimates and included unblinded trials.
Sham-controlled trials also enrolled different populations. VAPOUR studied 120 people with one or two recent fractures and severe pain; at 14 days, 44% of the vertebroplasty group and 21% of the sham group had pain below the trial's response threshold. VERTOS IV reported improvement in both groups but no significant between-group pain difference through twelve months. Symptom duration, baseline pain, eligibility, and outcomes varied.
The 300-participant randomized FREE trial reported greater early improvement in a physical-health score with balloon kyphoplasty than with nonsurgical care. At one month, the between-group difference in change on the SF-36 physical component score was 5.2 points. Because the comparison was not sham-controlled, it did not isolate cement placement from procedural context. The 2019 American Society for Bone and Mineral Research task force described evidence as insufficient to establish kyphoplasty benefit over nonsurgical care or other procedures. A NASS guideline summary published in 2025 recommended augmentation compared with medical treatment for acute fractures; its evidence review ended in September 2020.
Interactive evidence map
Vertebral fracture treatment literature
Select an evidence domain and lens to review reported findings and recurring limits in comparative studies and guideline summaries.
Evidence domain
Evidence lens
Natural history and nonprocedural care · Reported findings
Clinical reviews and guideline syntheses describe pain improvement over time for many people, with nonprocedural studies examining analgesia, bracing, activity, and bone-health treatment.
Educational. Not a diagnostic tool.
The augmentation literature compares different procedures, populations, and control groups; sham-controlled trials and unblinded comparisons with usual care do not measure the same treatment effect.
These evidence summaries are not interchangeable. Reviews differ in included trials, fracture duration and severity, and whether pain, function, quality of life, or radiographic change is the principal endpoint. Professional-society guidance also reflects a defined literature cutoff and comparator.
Reported complications, fracture progression, and prevention
Procedural series and reviews describe cement leakage as a frequent imaging finding, usually without symptoms, while serious events such as embolic complications, infection, or neural injury are reported less often. Estimates vary by imaging method, fracture type, procedure, and adverse-event collection. Small event counts limit estimates of rare harms.
Studies of new adjacent or distant vertebral fractures report uncertainty rather than a consistent causal effect. Height restoration, pain relief, function, cement leakage, and later fracture are distinct endpoints. Underlying osteoporosis and preexisting fractures recur in studies of future risk.
The NASS guideline reports conflicting evidence on new vertebral fractures after augmentation compared with medical treatment. It does not make a recommendation for or against augmentation on that outcome, reflecting uncertainty in the available comparative studies.
Osteoporosis guidance appears alongside literature on local fracture treatment. A prior vertebral fragility fracture is associated with elevated risk of additional fractures, and prevention studies examine post-fracture evaluation separately from evidence on augmentation for short-term pain.
Summary of the published evidence
Across clinical reviews, randomized trials, systematic reviews, and professional-society guidance, several themes recur. A vertebral deformity does not by itself establish fracture acuity or explain pain; marrow edema is interpreted with clinical context. Pain often improves, but the course varies. Vertebroplasty findings differ across sham and usual-care comparisons, while kyphoplasty studies report benefits over nonsurgical care with limits related to comparator design. Guidelines also differ in the questions and evidence periods they address. The literature describes population-level findings and uncertainty rather than one result for every fracture.
This overview is educational. It is not medical advice, does not evaluate any specific patient or matter, and does not substitute for review of the primary peer-reviewed sources.
Frequently asked
Common questions on this topic
What is an osteoporotic vertebral compression fracture?
It is a fragility fracture involving a vertebral body in the setting of reduced bone strength. Imaging may show vertebral height loss or wedging, but the appearance alone does not establish when the change occurred or whether it is causing current symptoms.
How do studies distinguish a recent fracture from an older deformity?
Studies use symptom timing and imaging findings. MRI marrow edema is commonly used as evidence of a recent or incompletely healed fracture, while radiographs and CT describe vertebral shape and bony morphology. Study definitions vary.
What does the literature report about the natural history of pain?
Clinical reviews and guideline summaries report that pain improves over time for many people, but the duration and degree of improvement vary. A subset of patients report persistent pain or functional limitation, and studies use different measures and follow-up periods.
How do vertebroplasty and kyphoplasty differ?
Both place cement within a vertebral body. Vertebroplasty injects cement directly, while balloon kyphoplasty uses an inflatable balloon to create a cavity before cement placement and may restore some vertebral height. Comparative evidence assesses pain, function, radiographic change, and complications separately.
Why do evidence summaries reach different conclusions about augmentation?
Trials compare procedures with different controls, including sham and usual care, and enroll groups with different fracture timing and pain severity. Systematic reviews and guidelines also use different inclusion criteria, endpoints, and evidence cutoffs, so their findings are not directly interchangeable.
About this article
This article is an educational summary of the peer-reviewed medical literature and current clinical practice on the topic addressed. It is written by Ahmer K. Ghori, MD, a board-certified orthopedic spine surgeon. It is not medical advice, does not evaluate any specific patient or matter, and does not substitute for review of the primary sources.
More educational articles are available on the Insights index.